4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-24-120876
Chief Science & Business Off bought 2,000 shares at $4.99 ($9,980)
From the SEC's structured data for this filing
Trades in this filing
Poradosu Enrique · Chief Science & Business Off
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-19 | Purchase : show line 1 in the form | +2,000 | $4.99 | $9,980 | 1,506,319 | D |
| Open-market purchases · 2,000 sh · avg $4.99 · $9,980 | ||||||
Loading xslF345X05/tm2428944-1_4seq1.xml…